April 9 (UPI) -- Eli Lilly announced that its GLP-1 weight-loss pill is available for purchase in the United States starting Thursday, little more than a week after the Food and Drug Administration approved it.
The Indianapolis-based pharmaceutical company said orforglipron, which goes by the brand name Foundayo, would be available for purchase for $149 per month at the lowest dose for self-pay patients. Those with insurance will pay as little as $25 per month.
Starting July 1, those on Medicare Part D could could the medication for $50 per month.
The FDA approved Foundayo for weight loss on April 1. It was the second GLP-1 drug in pill form approved by the agency. Until now, the drug had been approved only as a weekly injection.
Related
